Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2017 Financial Results
- Achieved Positive Phase 2 Results for Ralinepag in July, Phase 3 Preparations Underway<br>- Clinical Results from Additional Phase 2 Programs Expected Over the Next Several Quarters
View HTML
Toggle Summary Arena Pharmaceuticals to Release Second Quarter 2017 Financial Results and Provide Corporate Update on Monday, August 7, 2017
SAN DIEGO , July 31, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), today announced that the Company will release its second quarter 2017 financial results and provide a corporate update on Monday, August 7, 2017 , after the close of the U.S.
View HTML
Toggle Summary Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2017 Financial Results
- Clinical Data from Multiple Phase 2 Development Programs Expected in 2017 -<br>- Ralinepag Phase 2 Study Results Expected in July -
View HTML
Toggle Summary Arena Pharmaceuticals to Release First Quarter 2017 Financial Results and Provide Corporate Update on Tuesday, May 9, 2017
SAN DIEGO , May 2, 2017 /PRNewswire/ --  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), a biopharmaceutical company focused on developing novel, small molecule drugs across multiple therapeutic areas, today announced that the Company will release its first quarter 2017 financial results and provide a
View HTML
Toggle Summary Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2016 Financial Results
- Clinical Data from Multiple Phase 2 Development Programs Expected in 2017 -
View HTML
Toggle Summary Arena Pharmaceuticals to Provide Corporate Update and Release Fourth Quarter and Full-Year 2016 Financial Results on Tuesday, March 14, 2017
SAN DIEGO , March 06, 2017 (GLOBE NEWSWIRE) -- Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), today announced that the Company will provide a corporate update and release its fourth quarter and full-year 2016 financial results on Tuesday, March 14, 2017 , after the close of the U.S.
View HTML
Toggle Summary Arena Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Corporate Update
- Clinical Data from Phase 2 Development Programs Expected in 2017 -
View HTML
Toggle Summary Arena Pharmaceuticals to Release Third Quarter 2016 Financial Results and Provide Corporate Update on Monday, November 7, 2016
SAN DIEGO , Oct. 31, 2016 /PRNewswire/ -- Arena Pharmaceuticals, Inc. ( NASDAQ : ARNA), today announced that the Company will release its third quarter 2016 financial results and provide a corporate update on Monday, November 7, 2016 , after the close of the U.S.
View HTML
Toggle Summary Arena Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update
- Advancing Three Phase 2 Clinical Candidates -<br>- Conference Call and Webcast Scheduled for Today at 4:30 p.m. Eastern Time -
View HTML
Toggle Summary Arena Pharmaceuticals to Release Second Quarter 2016 Financial Results and Provide Corporate Update on Monday, August 8, 2016
SAN DIEGO , Aug. 1, 2016 /PRNewswire/ --  Arena Pharmaceuticals, Inc. ( NASDAQ : ARNA), today announced that the Company will release its second quarter 2016 financial results and provide a corporate update on Monday, August 8, 2016 , after the close of the U.S.
View HTML